CFR Pharmaceuticals S.A. (Chile)

CFR Pharmaceuticals S.A., a pharmaceutical company, engages in the research, development, manufacture, and commercialization of specialty branded generics and complex injectables. Its portfolio comprises products for the treatment of approximately 200 diseases and for general health care. The company offers specialty pharma products comprising women’s health, neurology, psychiatry, general medicine, pneumology, otorhinolaryngology, allergies, cardiology, dermatology, ophthalmology, and generic products. It also provides complex therapeutic drugs for the treatment of complex illnesses consisting sterile injectable products and lyophilized forms for anesthesia, infections, cardiology, and intensive care; and biological products, monoclonal antibodies, and treatments for dialysis, transplants, oncology, and rheumatology. In addition, the company offers over-the-counter products, nutrition products, food supplements, and homeopathic products. It operates in approximately 18 countries in the Americas, Europe, and Asia. The company was founded in 1922 and is based in Providencia, Chile. As of September 23, 2014, CFR Pharmaceuticals S.A. operates as a subsidiary of Abbott Laboratories.